Suscripción a Biblioteca: Guest
Portal Digitalde Biblioteca Digital eLibros Revistas Referencias y Libros de Ponencias Colecciones
Critical Reviews™ in Therapeutic Drug Carrier Systems
Factor de Impacto: 2.9 Factor de Impacto de 5 años: 3.72 SJR: 0.736 SNIP: 0.551 CiteScore™: 2.43

ISSN Imprimir: 0743-4863
ISSN En Línea: 2162-660X

Volumes:
Volumen 36, 2019 Volumen 35, 2018 Volumen 34, 2017 Volumen 33, 2016 Volumen 32, 2015 Volumen 31, 2014 Volumen 30, 2013 Volumen 29, 2012 Volumen 28, 2011 Volumen 27, 2010 Volumen 26, 2009 Volumen 25, 2008 Volumen 24, 2007 Volumen 23, 2006 Volumen 22, 2005 Volumen 21, 2004 Volumen 20, 2003 Volumen 19, 2002 Volumen 18, 2001 Volumen 17, 2000 Volumen 16, 1999 Volumen 15, 1998 Volumen 14, 1997 Volumen 13, 1996 Volumen 12, 1995

Critical Reviews™ in Therapeutic Drug Carrier Systems

DOI: 10.1615/CritRevTherDrugCarrierSyst.v20.i4.10
46 pages

Recent Progress in Polymeric Gene Delivery Systems

Khursheed Anwer
Expression Genetics, Inc., Huntsville, Alabama; and Valentis, Inc., 8301 New Trails Drive, The Woodlands, TX, USA
B. G. Rhee
Expression Genetics, Inc., Huntsville, Alabama, USA
Sanjeev Kumar Mendiratta
Expression Genetics, Inc., Huntsville, Alabama, USA

SINOPSIS

Considerable progress in polymeric gene delivery systems has been made over the last several years. First generation polymers have been replaced by safer and more efficient carrier systems through molecular functionalization, improving polymer biocompatibility, biological stability, cell-specificity, and intracellular trafficking. Many new polymers have moved from in vitro characterization to preclinical validation in animal models of cancer, diabetes, and cardiovascular disorders. Although the transfection efficiency of most polymeric carriers is still significantly lower than that of viral vectors, their structural flexibility allows for continued improvement in polymer activity. Also, simple manufacturing and scale-up schemes and the low cost of manufacturing are likely to eventually compensate for the performance gap between viral and polymeric vectors and establish clinical recognition and commercialization of polymer-based gene therapy drugs.


Articles with similar content:

Microparticles and Nanoparticles as Delivery Systems for DNA Vaccines
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.20, 2003, issue 2&3
Zhengrong Cui, Russell J. Mumper
Gene Delivery Using Lipoplexes and Polyplexes: Principles, Limitations and Solutions
Critical Reviews™ in Eukaryotic Gene Expression, Vol.29, 2019, issue 1
Amir Roointan, Najmeh Farahani, Esmat Safdarian, Seyed Mohammad Gheibi Hayat, Amirhossein Sahebkar
HIV-1 Vaccine Candidate Evaluation in Non-Human Primates
Critical Reviews™ in Oncogenesis, Vol.8, 1997, issue 2-3
Yichen Lu
Pediatric Rhabdomyosarcoma
Critical Reviews™ in Oncogenesis, Vol.20, 2015, issue 3-4
Jack F. Shern, Marielle E. Yohe, Javed Khan
Nanostructured Delivery Systems: Augmenting the Delivery of Antiretroviral Drugs for Better Management of HIV/AIDS
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.32, 2015, issue 6
Sanaul Mustafa, Roopa S Pai, Gurinder Singh